LOGIN  |  REGISTER
Recursion
Viking Therapeutics

Molina Healthcare Announces First Quarter 2023 Earnings Release and Conference Call Dates and Virtual Investor Day Meeting

March 16, 2023 | Last Trade: US$294.73 1.21 0.41

LONG BEACH, Calif. / Mar 16, 2023 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the first quarter ending March 31, 2023.

Molina Healthcare will issue its earnings release for the first quarter ending March 31, 2023, after the market closes on Wednesday, April 26, 2023, and will host a conference call and webcast to discuss the earnings release on Thursday, April 27, 2023, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 1543593. A telephonic replay of the conference call will be available through Thursday, May 4, 2023, by dialing (877) 344-7529 and entering the confirmation number, 5745408.

A live broadcast of Molina Healthcare’s conference call will be available on the Company’s website, molinahealthcare.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast.

2023 Virtual Investor Day

The Company also announced it will host a Virtual Investor Day meeting on Monday, May 15, 2023, beginning at 8:30 a.m. Eastern Time.

Investors can register for the event at www.molinahealthcareinvestorday.com/2023.

A 30-day online replay of the Investor Day meeting will be available approximately one hour following the conclusion of the live webcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company (currently ranked 125), provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 5.3 million members as of December 31, 2022. For more information about Molina Healthcare, please visit molinahealthcare.com.

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB